Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Regulatory pathways involving non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNA), have gained great relevance due to their role in the control of gene expression modulation. Using RNA sequencing of KSHV Bac36 transfected mouse endothelial cells (mECK36) and tumors, we have analyzed the host and viral transcriptome to uncover the role lncRNA-miRNA-mRNA driven networks in KSHV tumorigenesis. The integration of the differentially expressed ncRNAs, with an exhaustive computational analysis of their experimentally supported targets, led us to dissect complex networks integrated by the cancer-related lncRNAs Malat1, Neat1, H19, Meg3, and their associated miRNA-target pairs. These networks would modulate pathways related to KSHV pathogenesis, such as viral carcinogenesis, p53 signaling, RNA surveillance, and cell cycle control. Finally, the ncRNA-mRNA analysis allowed us to develop signatures that can be used to an appropriate identification of druggable gene or networks defining relevant AIDS-KS therapeutic targets.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242244 | PMC |
| http://dx.doi.org/10.3389/fonc.2021.687629 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the mechanism of phthalates in breast cancer using molecular docking and network toxicology.
Toxicol Mech Methods
September 2025
College of Public Health, Zhengzhou University, Zhengzhou, PR China.
Phthalate esters (PAEs) are ubiquitous environmental contaminants, with certain congeners potentially exhibiting breast cancer-promoting effects. However, their toxicological mechanisms remain poorly characterized. This study systematically investigates PAEs' direct interactions with breast cancer pathways using an integrated computational approach combining molecular docking-based inverse virtual screening with network toxicology.
View Article and Find Full Text PDFCase Report: From Kaposi's sarcoma to primary effusive lymphoma.
Front Med (Lausanne)
August 2025
Department of Dermatology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Primary effusion lymphoma (PEL) is a rare B-cell lymphoma with an extremely poor prognosis that is associated with long-term persistent latent infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV). However, studies on the correlation between KSHV genotype and PEL development in elderly patients are still lacking. We present the first global case of non-HIV, non-effusive, difficult-to-diagnose PEL with disseminated Kaposi's sarcoma (KS) in an elderly patient of Bouyei nationality, dynamically demonstrating that KSHV and EBV co-infection promote tumorigenesis.
View Article and Find Full Text PDFOncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation.
J Med Virol
August 2025
Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA.
Kaposi's sarcoma-associated herpesvirus (KSHV) is a human double-stranded DNA virus that is responsible for the development of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD), and KSHV inflammatory cytokine syndrome (KICS). KSHV infection manipulates distinct cellular proteins and signaling pathways, resulting in immune escape, cell death inhibition, infinite cell growth, and cancer formation. Current treatments for KSHV-associated cancers are limited to conventional strategies targeting nonviral cancers which encounter limited efficacy and drug resistance.
View Article and Find Full Text PDFNon-Coding RNAs and Immune Evasion in Human Gamma-Herpesviruses.
Viruses
July 2025
The Institute of Quantitative Biology, Biochemistry and Biotechnology (IQB3), School of Biological Sciences, The University of Edinburgh, Edinburgh EH9 3BF, UK.
Herpesviruses are DNA viruses that evade the immune response and persist as lifelong infections. Human gamma-herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV) are oncogenic; they can lead to cancer. Oncogenic viruses are responsible for 10-15% of human cancer development, which can have poor prognoses.
View Article and Find Full Text PDFOncoviruses in the Oral Cavity: Recent Advances in Understanding Viral Infections and Tumorigenesis.
Int J Mol Sci
July 2025
Laboratory of Molecular Virology and Parasitology, Oswaldo Cruz Institute (IOC/FIOCRUZ), Rio de Janeiro 21040-900, RJ, Brazil.
Oncoviruses, such as Epstein-Barr virus (EBV), human papillomavirus (HPV), and Kaposi sarcoma-associated herpesvirus (KSHV), have been widely discussed for their oncogenic risk. Initially, the oral cavity was disregarded. In recent years, orientation has shifted to the importance of the oral cavity and cancer-related issues via Handbook 19 titled "Oral Cancer Prevention" by the International Agency for Research on Cancer, the WHO Global Oral Health Status Report 2022, and multiple other actions focused on reducing the oversight of this neglected area.
View Article and Find Full Text PDF